Sun, Aug 31, 2014, 6:13 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • blank2thisone blank2thisone Mar 28, 2014 3:29 PM Flag

    NTM Community (NTMinfo) is enthusiatic!!...Guess they are the REAL experts!!

     

    The results of the clinical trial provide hope for NTM patients because this is the first drug to show efficacy against NTM in a clinical trial specifically designed to test it against the disease.

    Additionally, this was a trial for patients who have already had standardized treatments which failed to convert their sputum to culture negative. The fact that in this study conversion to culture negative occurred rather quickly is very exciting, and the information thus far suggests that ARIKAYCE™ may be less toxic than intravenous Amikacin.

    NTM Info & Research is greatly encouraged by the results of the ARIKAYCE™ study thus far, and we are hopeful that the medical community and industry will increase their focus on the diagnosis and treatment of NTM lung disease.

    NTMinfo dot org

    Sentiment: Strong Buy

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.93+0.11(+0.80%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.